hmmm....EBITDA in FY20 & FY21 was ~12m off revenues of 100-105m
FY2022 forecast revenues of 115m (so a ~9% inprovement) but resulting in a reduction in EBITDA ("low single-digit").
Their June strategy presentation indicated (at least for FY21) that EBITDA would be ~10% of revenues and long term (FY24) would improve to 15-20%, but this guidance seems to actually show EBITDA margins reducing.....more spend on R&D and S&M in the short term??
- Forums
- ASX - By Stock
- Ann: Gentrack provides updated guidance for FY22
hmmm....EBITDA in FY20 & FY21 was ~12m off revenues of...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTK (ASX) to my watchlist
|
|||||
Last
$9.97 |
Change
-0.080(0.80%) |
Mkt cap ! $1.047B |
Open | High | Low | Value | Volume |
$10.15 | $10.15 | $9.95 | $471.3K | 46.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 824 | $9.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.98 | 3827 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1133 | 9.960 |
5 | 326 | 9.950 |
5 | 673 | 9.940 |
4 | 252 | 9.930 |
4 | 985 | 9.920 |
Price($) | Vol. | No. |
---|---|---|
9.970 | 126 | 3 |
9.980 | 4381 | 5 |
9.990 | 212 | 4 |
10.000 | 726 | 2 |
10.010 | 489 | 3 |
Last trade - 13.41pm 11/09/2024 (20 minute delay) ? |
Featured News
GTK (ASX) Chart |